Independent research on the U.S. markets, Baptista Research

Baptista Research

Baptista Research is an independent financial research house focused on the U.S. markets. We provide equity research as well as credit research reports on the top-listed U.S. companies with most of our focus on technology, consumer goods and services, automobiles, industrials, oil and gas, pharma, and healthcare. Our research has served more than 3000 institutional investors including mutual funds, hedge funds, banks, family offices, and various buy-side firms. 

We operate a research subscription service where institutions, as well as retail investors, can have priority access to all our research. We also have a wide distribution of our research reports across some of the top global financial platforms. Apart from equity research and credit research, we also provide advisory services with respect to mergers & acquisitions (M&A), private equity/ venture capital fundraising, valuation reports, and investment management services for corporates.
Baptista Research is owned and managed by Ishan Majumdar, an ex-Venture Capitalist/ Investment Banker, a Chartered Accountant, and a Masters’ degree holder in Management from HEC Paris. Ishan has nearly a decade of experience in Mergers and Acquisitions, Leveraged Buyouts (LBOs), Venture Capital Investing, Corporate Strategy, and Valuation in front-office roles at the likes of BNP Paribas CIB, Credit Agricole CIB, Groupe Danone, and TIW Private Equity. He has worked on and closed multiple acquisition deals, leveraged buyouts, and start-up investment transactions.

Independent research on the U.S. markets

TESLA (TSLA US) Tactical Outlook Amid Rumors of Elon Musk's Replacement

Baptista Research is an independent financial research house focused on the U.S. markets. We provide equity research as well as credit research reports on the top-listed U.S. companies with most of our focus on technology, consumer goods and services, automobiles, industrials, oil and gas, pharma, and healthcare. Our research has served more than 3000 institutional investors including mutual funds, hedge funds, banks, family offices, and various buy-side firms. We operate a research subscription service where institutions, as well as retail investors, can have priority access to all our research. We also have a wide distribution of our research reports across some of the top global financial platforms. Apart from equity research and credit research, we also provide advisory services with respect to mergers & acquisitions (M&A), private equity/ venture capital fundraising, valuation reports, and investment management services for corporates.
Baptista Research is owned and managed by Ishan Majumdar, an ex-Venture Capitalist/ Investment Banker, a Chartered Accountant, and a Masters’ degree holder in Management from HEC Paris. Ishan has nearly a decade of experience in Mergers and Acquisitions, Leveraged Buyouts (LBOs), Venture Capital Investing, Corporate Strategy, and Valuation in front-office roles at the likes of BNP Paribas CIB, Credit Agricole CIB, Groupe Danone, and TIW Private Equity. He has worked on and closed multiple acquisition deals, leveraged buyouts, and start-up investment transactions.

Equity Bottom-Up

<ul><li>Tesla's first quarter of 2025 earnings revealed a company navigating immediate difficulties while maintaining focus on long-term opportunities.</li><li>Despite declines in sales, operating income, and profit margins compared to the previous year, Tesla's stock surged 5.4%, largely because investors had anticipated weak results after a 13% year-over-year drop in deliveries.</li><li>Critical to the stock's resilience was the reaffirmation that Tesla’s timeline for launching a lower-priced vehicle remains intact, with production expected to begin in the first half of 2025.</li></ul>

Tesla's first quarter of 2025 earnings revealed a company navigating immediate difficulties while maintaining focus on long-term opportunities.Despite declines in sales, operating income, and profit margins compared to the previous year, Tesla's stock surged 5.4%, largely because investors had anticipated weak results after a 13% year-over-year drop in deliveries.Critical to the stock's resilience was the reaffirmation that Tesla’s timeline for launching a lower-priced vehicle remains intact, with production expected to begin in the first half of 2025.

테슬라의 대담한 새로운 움직임: 저렴한 자동차, 로보택시, 그리고 투자자들이 예상하지 못했던 주가 급등!